Month: July 2019

Global Hepatitis B Market Size

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant

1 in every 100,000 persons get infected with Hepatitis B virus every year at a stable rate from the past three decades. Moreover, the WHO...

Read More

Idiopathic Pulmonary Fibrosis Market Landscape and Forecast

Articles, Business Consultant, DelveInsight's Drug Report, Pharma Consultant

According to NIH, Idiopathic Pulmonary Fibrosis prevalent cases are estimated to be 13 to 20 per 100,000 people worldwide, making it’s a...

Read More

Pharma Week | Baqsimi wins FDA nod for Hypoglycemia; Freenome captures USD 160M; FDA approval for Ruxience for leukaemia

Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

FDA Approves Eli Lilly’s Baqsimi, the first treatment for Severe Hypoglycemia The U.S. FDA gave its approval to Baqsimi nasal powder,...

Read More

Parkinson’s Disease: 5 stages, Risk Factors, Prevention, Gene Therapy

Articles, Business Consultant, Pharma Consultant

Parkinson’s Disease is a condition that involves dysfunction or loss of dopamine-producing neurons in the brain. The hallmarks of this...

Read More
Close